Biogen Lifts Outlook As Rare Disease And Alzheimer's Drug Sales Accelerate

benzinga.com/markets/earnings/25/07/46764173/biogen-lifts-outlook-as-rare-disease-and-alzheimers-drug-sales-accelerate

Biogen Inc. (NASDAQ:BIIB) reported on Thursday that the second quarter of 2025 adjusted earnings per share were $5.47, up 4% year over year, beating the analyst consensus of $4.06.
The company reported sales of $2.65 billion, up 7% year over year on a reported basis, 8% on constant…

This story appeared on benzinga.com, 2025-07-31 15:49:58.
The Entire Business World on a Single Page. Free to Use →